September 2021 - Page 2 of 2

MondaySep 13, 2021 12:32 pm

Flora Growth Corp. (NASDAQ: FLGC) Expands Across International Borders into Europe and Asia

Flora Growth business divisions include pharmaceuticals, cosmetics, hemp textiles, and food & beverage sectors Flora Lab now has three GMP certifications – one each for cosmetics, phytotherapeutic products, and dietary supplements Flora Growth operates internationally but has its cultivation and processing operations based in Colombia – with one of the largest outdoor cultivation facilities in the world, aiming to produce medical-grade cannabis flower and derivative products at below-market pricing Proposed acquisitions of Vessel Brand and Koch & Gsell, as well as investment into Hoshi International, will help expand the business across international borders and into the US, Europe, and Asia…

FridaySep 10, 2021 9:15 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Marks Impressive Performance for Q2 2021

$58.5 million in Adjusted Sales for first six months of 2021 The company also reported repaying approximately $18 million of debt and restructuring over $20 million into a long-term debt Q2 also marked RWB’s acquisition of Acreage Florida, as well as an operational 45,000 SF greenhouse within the state, which it projects, will begin harvesting in Q4 2021 RWB’s CEO expressed his optimism about the company’s performance in the Q3 and the second half of the year, given the strides made and the momentum realized in Q2 On August 30, Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) released…

ThursdaySep 09, 2021 1:28 pm

Flora Growth Corp. (NASDAQ: FLGC) Inks €2M Investment in Hoshi As Part of its European Expansion Plan

Flora closed a €2 million investment in Hoshi International Inc., fulfilling the earlier-announced LOI back in June 2021 This move is set to capitalize on Hoshi’s strong European presence, its technical know-how along with its understanding of the European market Hoshi acknowledged the investment with the announcement that it would work together with Flora to bring to market finished product formats from Flora’s brand portfolio Flora referred to this investment as the first of many steps by the company to advance its plans to launch products across the world On August 24, 2021, Flora Growth (NASDAQ: FLGC) announced closing a…

ThursdaySep 09, 2021 12:59 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) to Address Advances in its Bioavailability Technology DehydraTECH(TM) at Wainwright Life Sciences Conference

Drug delivery technology innovator Lexaria Bioscience is celebrating the positive outcomes of clinical testing of its trademarked DehydraTECH platform for reducing the blood stream delivery time of anti-virals, NSAIDS and potential hypertension treatments Lexaria will participate in H.C. Wainwright’s annual Global Investor Conference this month to help bring further attention to its successes The DehydraTECH technology enhances the delivery of pharmaceuticals that can be administered orally, and testing has shown no adverse chemical compounds have been created in the process The COVID-19 pandemic has raised the profile of the anti-viral medication market, enhancing the opportunities for Lexaria’s revenue stream As…

WednesdaySep 08, 2021 9:30 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) is Changing Absorption of Fat-Soluble Compounds Through Patented DehydraTECH(TM) Technology

Lexaria Bioscience Corp. and its patented DehydraTECH technology promote a more effective, less expensive form of oral drug delivery evaluated thoroughly in vivo, in vitro, and human clinical testing DehydraTECH is sub-licensed to other companies in select countries, and is in close collaboration with the largest R&D organization in Canada, the National Research Council, since January 2017 The technology is suitable for use with a wide range of product formats, including pharmaceuticals, nutraceuticals, consumer packaged goods, and over-the-counter (“OTC”) capsules, pills, tablets, and oral suspensions DehydraTECH-enabled drugs offer multiple benefits, including faster delivery, increased bioavailability, increased brain absorption, improved drug…

FridaySep 03, 2021 1:43 pm

Golden Triangle Ventures Inc. (GTVH) Announces Successful Results of HyGrO Technology Testing

Preliminary testing indicates that water produced using HyGrO’s patent-pending technology could increase shelf life of cut flowers The HyFrontier team is partnering with a commercial-scale flower producer to evaluate effects of HyGrO technology on larger list of flower varieties Positive study results will assist the company as it rolls out new technology After reporting the successful results of preliminary testing, Golden Triangle Ventures (OTC: GTVH) is looking forward to pursuing larger-scale studies of its proprietary HyGrO hydrogen water technology. The company will work with commercial-scale flower products to further evaluate the efficacy of GTVH’s new process. “There are no words…

FridaySep 03, 2021 12:41 pm

Hero Technologies Inc. (HENC) Subsidiary Committed to ‘Set the Gold Standard for American CBD’

Cannabis company founded by veterans vows to meet highest of standards Veteran HempCo was founded with mission to provide quality, American-made, wholesale CBD products to health, wellness and beauty businesses Company has access to some of the best hemp flower in the country As the cannabis industry grows and an increasing number of companies rush to enter the space, Hero Technologies (OTC: HENC) and its wholly owned subsidiary Veteran HempCo vow to hold themselves and their products to the highest of standards (https://cnw.fm/3gZnK). The subsidiary offers another unique aspect to cannabis company ownership: the company was founded by veterans. Initially, this…

ThursdaySep 02, 2021 12:21 pm

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Ideally Situated in Burgeoning Cannabis Beverage Sector

EMR report projects that North America is likely to be fastest, largest marketplace for cannabis beverages Cannabis beverage industry projected to grow at CAGR of 48% in the next five years, reaching an anticipated $12.7 billion by 2026 BevCanna manufactures its own beverage product lines, offers white-label services to companies looking for the highest-quality products available North America will be a leader in the global cannabis beverage market, according to a recent Expert Market Research (“EMR”) report (https://cnw.fm/KFpSc). This projection bodes well for BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), a diversified health & wellness beverage and natural products…

WednesdaySep 01, 2021 11:23 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Targets Burgeoning Hypertension, Antiviral Therapeutics Markets with Drug Delivery Technology

Lexaria has progressed significantly in evidencing that its patented DehydraTECH(TM) drug delivery technology can sufficiently improve the usable fraction of known antiviral drugs that reach the bloodstream According to a Newsfile Corp. article, this technology can be applied to rendering treatments for HIV/AIDS and other infectious diseases more effective The company also released partial results from a human clinical study evaluating DehydraTECH-processed CBD for potential application against hypertension, which evidenced a rapid and sustained drop in blood pressure Growing hypertension and antiviral therapeutics market represent a potential win for Lexaria In July, Lexaria Bioscience (NASDAQ: LEXX), a drug delivery technology…

News and publishing service for hemp related companies

Contact us: 303.498.7722

Month: September 2021